On March 24, 2022, the Center for Contemporary Sciences (CCS) is pleased to host its first Investor Summit 2022. This one-of-a-kind business development event, held in partnership with Beyond Animal, is open to the public and brings together an international group of innovators, investors, researchers, start-ups, and venture philanthropists.
The three-hour-event is designed to promote the cross-pollination of ideas, provide much needed exposure to business entities, and unlock entrepreneurial potentials under proper, expert guidance. The goal of the summit is to further the engagement among scientists, investors, and the business community, specifically in the fields of human-relevant alternatives to animal experimentation and testing.
Among the invited participants are trailblazers in biomedical innovation and Organ-Chip technology like MatTek, Tissue Dynamics, and NETRI; Bioprinting leaders such as CELLINK; Experts in advancing regenerative medicine therapies like ReMDO; And the animal-free cosmetics industry pioneer, XCellR8. That is in addition to a wide network of investors seeking to learn more about new opportunities in these areas.
“CCS is committed to changing the current paradigm in drug development and academic research that still relies heavily on ineffective animal research,” said Zaher Nahle PhD MPA, CCS’S Chief Science Officer and the Summit’s moderator and host. “This summit is part of our overall strategy to advance the discovery process and create healthier, more compassionate societies – Sparking both interest and investments in promising, human-relevant businesses and endeavors,” Nahle adds.
Through discerning public policy efforts, targeted pharmaceutical outreach, collaborations with academia, building bridges among scientists and entrepreneurs, and partnering with committed entities like Beyond Animal, CCS is driving forward much needed change and filling knowledge gaps.
“This is the first ever investor summit specifically focused on replacing the use of animals with more human-relevant testing methods,” says CCS CEO Aysha Akhtar, MD, MPH. “We have been seeing more companies emerge that are focused on developing tools that can better help us understand human diseases and find treatments than artificial animal testing. These tools are the future of medicine, and we are excited to be helping to launch this future.”
To participate in this informative event on March 24, 2022 at Noon (EST), you can register for free at Beyond Animal. Subscribe also to email updates on our website to stay informed about similar programs from CCS in the future.